tert-Butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate

Catalog No. :
ACMHEY985
CAS No. :
271245-38-6
Molecular Formula :
C14H25NO3
Molecular Weight :
255.36

IUPAC Name:tert-butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate

tert-Butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$593.00Login to see priceInquiryInquiry
250mg97%$1112.00Login to see priceInquiryInquiry
1g97%$2226.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate
IUPAC Nametert-butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate
MDL No.MFCD04116218
Molecular FormulaC14H25NO3
Molecular Weight255.36
SMILESO=C(N1CCOC2(CCCCC2)C1)OC(C)(C)C
InChI KeyRAGJPHPLTSYIBT-UHFFFAOYSA-N
Synonym4-BOC-1-OXA-4-AZASPIRO[5.5]UNDECANE;tert-butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate;tert-butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate(WXC07266);1-Oxa-4-azaspiro[5.5]undecane-4-carboxylic acid, 1,1-dimethylethyl ester
CAS No.271245-38-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMHEY985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIUBQ647 route compound structure diagram
    ACIUBQ6471354951-87-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMHEY985 route product structure diagram
    ACMHEY985271245-38-6
Inquiry

2. ACMHEY985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMHEY985 route product structure diagram
    ACMHEY985271245-38-6
Inquiry

Comments (0)